Registry for SETD2 Neurodevelopmental Disorder

Go Back to All Clinical Trials

Registry for SETD2 Neurodevelopmental Disorder

Brief description of study

The purpose of this research study is to collect different type of information about individuals affected by SETD2-neurodevelopmental disorder and their parents/guardians so that the researchers can learn more about the condition. SETD2-neurodevelopmental disorder is rare, with less than 40 individuals currently reported in the medical literature. The researchers hope to gather information regarding the syndrome and establish a clinical presentation of associated syndromes.

Clinical Study Identifier: s22-00717

ClinicalTrials.gov Identifier: NCTTX1811

Principal Investigator: John G Pappas.

Other Investigator: Rachel Bari Rabin.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies